Oraya Therapeutics Raises $42 Million in Series C Financing 7/20/2009
More...
|
Potentia Pharmaceuticals, Inc.'s POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 5/4/2009
More...
|
Ophthotech Corporation Announces Positive Results for Ophthotech's Novel Therapy for Wet AMD 5/4/2009
More...
|
Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide 4/15/2009
More...
|
FDA Advisory Panel Recommends Approval of VisionCare Ophthalmic Technologies' Implantable Telescope for End-Stage Macular Degeneration 3/31/2009
More...
|
ArcticDx Inc. Announces Revolutionary Genetic Test Now Available for Age-Related Macular Degeneration 3/10/2009
More...
|
Opko Health, Inc. Announces Completion of Enrollment for Its Phase III Clinical Trial of Bevasiranib for Treatment of AMD 12/4/2008
More...
|
LSGPA Invests $500,000 in Apeliotus Vision Science, Inc. 11/18/2008
More...
|
Poor Night Vision May Predict Age-Related Eye Disease, University of Pennsylvania School of Medicine Study 11/14/2008
More...
|
Potentia Pharmaceuticals, Inc.' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial AMD Patients Treated with POT-4 Demonstrate No Adverse Toxic Effects 11/10/2008
More...
|
Ophthotech Treats First Patient in a Phase I Trial of Monoclonal Antibody, Volociximab, for Age-Related Macular Degeneration 11/10/2008
More...
|
American Academy of Ophthalmology Release: Glycemic Control Appears to Reduce Type 1 Diabetics’ Retinopathy Risk; Night Vision Symptoms May Predict Macular Degeneration Progression 11/3/2008
More...
|
Othera Pharmaceuticals Announces First U.S. Patent Issued On New Class of Compounds to Treat AMD and Other Ophthalmic Diseases 10/28/2008
More...
|
Ophthotech Enrolls First Patient in a Phase I Complement (Anti-C5) Inhibitor Trial for Macular Degeneration 10/27/2008
More...
|
Lpath, Inc. Initiates Dosing in Phase 1 Trial for AMD 10/16/2008
More...
|
Too Much Sun, Too Few Antioxidants Spell Eye Trouble, London School of Hygiene and Tropical Medicine Study 10/15/2008
More...
|
Case Western Reserve University Research Finds Drug Candidate Slows Age-Related Macular Degeneration 10/10/2008
More...
|
Lpath, Inc. Publishes First-in-Class Therapeutic Results With iSONEP(TM), Its Ocular Drug Candidate 10/8/2008
More...
|
Genetic Link To Age-Related Macular Degeneration Reported, University of Southampton Study 10/7/2008
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) and Bayer HealthCare AG (BAY) Release: VEGF Trap-Eye Final Phase 2 Results in Age-related Macular Degeneration Presented at 2008 Retina Society Meeting 9/29/2008
More...
|
Arana Therapeutics Updates Inflammatory Pipeline Milestones 9/22/2008
More...
|
Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration 9/4/2008
More...
|
American Academy of Ophthalmology Release: Use of Electronic Health Records by Eye M.D.s; Two Studies Refine Risks and Predictors for Advanced Macular Degeneration 9/2/2008
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) and Bayer HealthCare AG (BAY) Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration 8/19/2008
More...
|
Alcon Laboratories, Inc. (ACL) Ends Macular Degeneration Drug Program 7/14/2008
More...
|
Pipex Pharmaceuticals (PPXP) Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD); Study Meets All Global Central Retinal Function Measurements 7/9/2008
More...
|
Acucela Inc. Doses First Subject in Phase I Trial for Age-Related Macular Degeneration 6/3/2008
More...
|
pSivida Limited (PSD.AX) Announces Start of Clinical Trial to Assess Safety and Efficacy of Medidur(TM) FA in Patients with Age Related Macular Degeneration Treated with Lucentis(R) 5/8/2008
More...
|
Bayer HealthCare (BAY) and Regeneron Pharmaceuticals, Inc. (REGN) Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 5/8/2008
More...
|
Alimera Sciences Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R) 5/8/2008
More...
|
Ranibizumab Injections Reduce Retinal Swelling, Johns Hopkins Wilmer Eye Institute Study 5/2/2008
More...
|
PhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration 4/22/2008
More...
|
Hormone Use Related To Lower Risk Of Macular Degeneration In Postmenopausal Women, Brigham and Women's Hospital and Harvard Medical School Study 4/15/2008
More...
|
QLT Inc. (QLTI) Positive Results from Visudyne(R) Combination Therapy Study Reported at Annual Macula Society Conference 3/28/2008
More...
|
Electric Current Touted As Cure For Eye Diseases, ScyFIX Clinical Trial Continues 3/10/2008
More...
|
American Academy of Ophthalmology Release: New Clues to the Causes of Age-Related Macular Degeneration (AMD) 2/27/2008
More...
|
MacuSight, Inc. Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration Sirolimus Demonstrates Favorable Safety Profile and Improvements in Visual Acuity 2/25/2008
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 2/22/2008
More...
|
Ophthotech Enrolls Its First Patient in a Phase I Anti-PDGF Macular Degeneration Trial 2/12/2008
More...
|
NeoVista, Inc. First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD Ophthalmic Clinic in Germany First in Europe To Treat Patients With New Focused Radiation Therapy 11/29/2007
More...
|
Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies 11/6/2007
More...
|
OccuLogix Inc. (OCCX) Suspends RHEOTM System Clinical Development Program 11/1/2007
More...
|
Optherion, Inc. Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics 10/23/2007
More...
|
Genentech, Inc. (DNA) (Jobs) to Curb Avastin Sales for Eye Illness 10/12/2007
More...
|
Elevated Inflammatory Marker May Be Linked to Increased Risk of Age-Related Eye Disease 10/9/2007
More...
|
Optherion, Inc. Completes $37 Million Start Up Financing; Will Advance Development of Diagnostics and Disease-Modifying Therapeutics 10/9/2007
More...
|
Jerini AG Ophthalmic Treats First Patient in Phase I Trial for Age-related Macular Degeneration 10/9/2007
More...
|
Sirtris Pharmaceuticals (SIRT)' Oral Drug Candidate SRT501 Shown To Be Neuroprotective: Implications for SIRT1 Activation in Neurodegenerative Eye Disorders 10/9/2007
More...
|
Limiting Refined Carbohydrates May Stall AMD Progression, Tufts University Study 10/8/2007
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Announces Positive Primary Endpoint Results from a Phase 2 Study of VEGF Trap-Eye in Age-related Macular Degeneration 10/1/2007
More...
|
FDA Wants Another Study to OK Alcon Laboratories, Inc. (ACL) Eye Disease Drug 9/25/2007
More...
|
Opko Health, Inc. Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD 8/30/2007
More...
|
Scientists Develop Implantable Telescope 8/15/2007
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Receives $20 Million Milestone Payment for Initiation of Phase 3 Study of VEGF Trap-Eye in Wet AMD 8/14/2007
More...
|
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration 8/13/2007
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) and Bayer HealthCare AG (BAY) Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD) 8/3/2007
More...
|
TargeGen, Inc. Initiates Multi-Center Phase II Clinical Trial Of TG100801, a Topically Applied Kinase Inhibitor In Macular Degeneration Patients 7/30/2007
More...
|
Opko Health, Inc. Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD 7/11/2007
More...
|
Pipex Pharmaceuticals (PPXP) Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD) 7/10/2007
More...
|
Advanced Cell Technology Announces Critical Advancements in Its RPE Program for the Treatment of Macular Degeneration and Other Retinal Degenerative Diseases 6/20/2007
More...
|
University College London Scientists Plan Stem Cell Cure for Blindness 6/6/2007
More...
|
Lpath, Inc. Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab(TM) 5/22/2007
More...
|
Nutrients Found to Cut Macular Degeneration Risk 5/15/2007
More...
|
OXiGENE (OXGN) Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT(TM) CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology 5/7/2007
More...
|
VisionCare Ophthalmic Technologies Announces Presentations on Implantable Telescope for End-Stage Macular Degeneration at ARVO Annual Meeting 5/1/2007
More...
|
Genes Matter in Progression of Macular Degeneration 4/25/2007
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Release: Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration 3/27/2007
More...
|
Potentia Pharmaceuticals, Inc. Announces Initiation of Phase I Clinical Trials to Evaluate its Lead Compound for Age-Related Macular Degeneration 3/20/2007
More...
|
International Stem Cell Corporation Subsidiary Lifeline Cell Technology, LLC Enters into Agreement with University of California to Study Macular Degeneration and Retinitis Pigmentosa 3/19/2007
More...
|
TargeGen, Inc. Announces Successful Completion of Phase I Clinical Trial of Topical AMD Drug TG100801 2/28/2007
More...
|
OXiGENE (OXGN) Drug Met Goal; Announces Positive Results From Its Phase II CA4P Clinical Trial In Myopic Macular Degeneration (MMD-213) 2/15/2007
More...
|
SR Pharma PLC (SPA.L) Announces Start Of Phase I Trial With Novel RNAi Therapeutic RTP-801i In Age-Related Macular Degeneration (AMD) 2/5/2007
More...
|
Athenagen Inc.'s Eye Drop Therapy For AMD Is Safe And Well Tolerated In Phase I Study 1/31/2007
More...
|
Genentech, Inc. (DNA) (Jobs) Warns Doctors Of Lucentis Stroke Risk 1/29/2007
More...
|
OccuLogix Inc. (RHEO)'s RHEO-AMD Trial Protocol Cleared By The FDA 1/29/2007
More...
|
Genaera Corporation (GENR) Terminates EVIZON(TM) Clinical Program And Restructures 1/4/2007
More...
|
Pharmion Corporation (PHRM) Release: New Data Validate Vidaza(R) Response Rates In MDS And Report Results In AML 12/11/2006
More...
|
Gene Linked To Aggressive "Wet" Age-Related Macular Degeneration 11/27/2006
More...
|
Advanced Cell Technology Comments On The Results Of The Midterm Elections 11/14/2006
More...
|
CellGate, Inc. Initiates Phase I Clinical Study In Age-Related Macular Degeneration 11/8/2006
More...
|
Laser Treatment Not Effective In Preventing Vision Loss For People With Early AMD 11/1/2006
More...
|
TargeGen, Inc. Initiates Phase I Clinical Trial Of Topical AMD Drug TG100801 11/1/2006
More...
|
MacuSight, Inc. Initiates Wet Age-Related Macular Degeneration Study 10/31/2006
More...
|
OccuLogix Inc. (RHEO) And Asahi Kasei Medical America Sign Rheofilter'TM' SR Agreement 10/23/2006
More...
|
Protein Find Could Be Key To Treating Eye Disorder 10/19/2006
More...
|
Lucentis Effective For Common Cause Of Blindness 10/5/2006
More...
|
The New England Journal of Medicine Publishes Data From Genentech, Inc. (DNA)'s Lucentis Pivotal Phase III Studies In Wet Age-Related Macular Degeneration 10/5/2006
More...
|
The New England Journal of Medicine Report: Bascom Palmer Specialist's Study Shows Significant Vision Improvement For Patients With Wet AMD 10/5/2006
More...
|
OXiGENE (OXGN) To Focus Ophthalmology Strategy Toward Non-Invasive Administration Of CA4P For Age-Related Macular Degeneration (AMD); Closes Enrollment Of Phase II CA4P Clinical Trial In Myopic Macular Degeneration (MMD-213) 9/12/2006
More...
|
Acuity Pharmaceuticals Reports Positive Phase II Results For Bevasiranib In Wet AMD 9/11/2006
More...
|
Novadaq Technologies, Inc. Updates On OPTTX Clinical Results As Presented At This Year's Joint American Society Of Retina Specialists And European Vitreo Retinal Society Meeting 9/11/2006
More...
|
Case And Cleveland Clinic Researchers Identify Molecule In Age-Related Macular Degeneration 9/7/2006
More...
|
Athenagen Inc. Initiates Clinical Development Of Its Anti-Angiogenic Eye Drop Therapy For AMD 8/21/2006
More...
|
Advanced Refractive Technologies Inc. Achieves Early Milestone 8/17/2006
More...
|
Sirna Therapeutics, Inc. (RNAI) Reports Final Results From Phase 1 Study On Its RNAi-Based Therapeutic For Age-Related Macular Degeneration 8/10/2006
More...
|
Genetic Variation Linked To Age-Related Macular Degeneration 7/19/2006
More...
|
Genentech, Inc. (DNA) Release: FDA Approves LUCENTIS For The Treatment Of Wet Age-Related Macular Degeneration 6/30/2006
More...
|
EVIZON(TM) Phase II Clinical Trial Begins Enrollment Of Patients With Wet Age-Related Macular Degeneration 6/26/2006
More...
|
OSI Pharmaceuticals, Inc. (OSIP) And Pfizer Inc. (PFE) Announce Phase IV Macugen(R) Maintenance Trial In Neovascular Age-Related Macular Degeneration (AMD) 6/26/2006
More...
|
Novartis Ophthalmics AG (NVS) Gets Canadian License For Eye Disorder Treatment 6/22/2006
More...
|
Genaera Corporation (GENR) To Present At IBC Ocular Anti-Angiogenesis Conference 6/22/2006
More...
|
OccuLogix Inc. (RHEO) Reports On Meeting With FDA; Agency Requires Additional Study Of The RHEO(TM) System 6/12/2006
More...
|
Genentech, Inc. (DNA) Release: Preliminary Results From A Phase IIIb Study Showed Patients With Wet AMD Treated With Lucentis Quarterly Experienced A 16-Letter Benefit Over The Control Group At One Year 6/2/2006
More...
|
Acuity Pharmaceuticals Reports Positive Initial Phase II Results For Bevasiranib (Cand5) In Wet AMD 6/1/2006
More...
|
ZeaVision, LLC Release: St. Louis Business Eyes Local Market As First In Country To Screen For AMD Risk 5/24/2006
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Summarizes Macugen(R) Data Presented At Association For Research In Vision And Ophthalmology (ARVO) Meeting 5/5/2006
More...
|
Sangamo BioSciences, Inc. (SGMO) Presents Preclinical Data From ZFP Therapeutic For Age- Related Macular Degeneration 5/3/2006
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Reports Positive Phase 1 Data For The VEGF Trap In Age-Related Macular Degeneration 5/2/2006
More...
|
pSivida Limited (PSD.AX) Announce Rights Issue To Fund Late Stage Macular Edema Trials And Commencement Of Pancreatic Cancer Trials 5/2/2006
More...
|
TargeGen, Inc. Presents Data For TG100801, A Topically Applied Compound For The Potential Treatment Of Major Eye Diseases Including Macular Degeneration 4/6/2006
More...
|
Othera Pharmaceuticals And The National Eye Institute Collaborate In Dry AMD Study 4/5/2006
More...
|
OccuLogix Inc. (RHEO) Reports Positive MIRA-1 Analysis Results 3/9/2006
More...
|
GenVec Inc. (GNVC) Completes Enrollment In AdPEDF Clinical Study For Macular Degeneration 3/7/2006
More...
|
New Genetic Discovery Explains 74 Percent Cases Of Age-Related Macular Degeneration 3/6/2006
More...
|
Genaera Corporation (GENR) Announces Interim EVIZON(TM) Phase II (MSI-1256F-209) Data 3/2/2006
More...
|
Genentech, Inc. (DNA) Granted Six-Month Priority Review For Lucentis For The Treatment Of Wet Age-Related Macular Degeneration 3/1/2006
More...
|
GenVec Inc. (GNVC) Macular Degeneration Study And Supporting Editorial Published In February Issue Of Human Gene Therapy 2/7/2006
More...
|
OccuLogix Inc. (RHEO) Stock Dives 70% On Phase III Study Disappointment 2/3/2006
More...
|
Regeneration Technologies Inc. (RTIX)'s VEGF Trap Demonstrates Positive Preliminary Results In Patients With Age-Related Macular Degeneration 2/3/2006
More...
|
Pfizer Inc. (PFE) Release: European Commission Approves Macugen For Treatment Of All Types Of Wet Age-Related Macular Degeneration; First Treatment To Target Underlying Disease Process Of Wet AMD 2/2/2006
More...
|
University of Kentucky Researcher Identifies Key To Macular Degeneration Progression 1/31/2006
More...
|
OcuCure Therapeutics Release: Age-Related Macular Degeneration Fighting Company Receives Investment 1/31/2006
More...
|
Inspire Pharmaceuticals (ISPH) Discontinues Trials Of Retinal Disease Drug 1/20/2006
More...
|
Clinical Trial On Gene Therapy For Macular Degeneration Published In Human Gene Therapy 1/17/2006
More...
|
Genentech, Inc. (DNA) Release: Preliminary Phase III Data From Head-To-Head Study Of Lucentis Shows Lucentis Improved Vision Compared To Visudyne In Patients With Wet Age-Related Macular Degeneration 1/16/2006
More...
|
Neurotech Initiates A Phase II Clinical Trial Of NT-501 For The Treatment Of Dry Age Related Macular Degeneration 1/5/2006
More...
|
Biomarker For Age-Related Macular Degeneration Found 1/4/2006
More...
|
Genentech, Inc. (DNA) Submits Biologics License Application For FDA Review Of Lucentis(TM) In Wet Age-Related Macular Degeneration 12/30/2005
More...
|
Passive Smoking May Increase Vision Problems 12/21/2005
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces Update To Timing Of European Union Approval For Macugen(R) 12/14/2005
More...
|
Alcon Laboratories, Inc. (ACL) Receives Approval Of RETAANE(R) Suspension In Australia 12/13/2005
More...
|
MultiCell Technologies Inc. (MCET.OB) And Columbia University Begin Joint Research Program 12/1/2005
More...
|
All 12-Month Follow-Up Visits Completed In OccuLogix Inc. (RHEO)'s Pivotal Trial For Dry Age-Related Macular Degeneration 11/17/2005
More...
|
Genentech, Inc. (DNA) Says Ready To Seek FDA OK For Eye Drug; Preliminary Data From Phase III Trial Show Lucentis Is the First Investigational Therapy To Demonstrate Clinical Benefit Over Visudyne In A Head-to-Head Study Of Patients With Wet AMD 11/8/2005
More...
|
Genaera Corporation (GENR) Presents Positive Preliminary Clinical Results for EVIZON(TM) For Treatment Of Age-Related Macular Degeneration 10/19/2005
More...
|
Sirna Therapeutics, Inc. (RNAI) Announces Updated Phase I Clinical Trial Data For Sirna-027 10/19/2005
More...
|
Acuity Medical Proceeds With FDA Pre-market Approval Application For TheraMac(TM) 10/17/2005
More...
|
Safety Of Alcon Laboratories, Inc.'s (ACL) RETAANE(R) Suspension Confirmed At 24 Months 10/14/2005
More...
|
Acuity Pharmaceuticals Initiates Phase II Trial Of Cand5 In Wet AMD Following Successful Completion Of Phase I 10/14/2005
More...
|
OccuLogix Inc. (RHEO) Says FDA OKs Plan For Regulatory Submission 10/11/2005
More...
|
Genaera Corporation (GENR) Announces Preliminary Phase II Data Showing EVIZON(TM) With Visudyne(R) Demonstrate Safety And Stabilization Of Vision In Wet Age-Related Macular Degeneration 10/11/2005
More...
|
Acuity Medical Macular Degeneration Device Shows Positive Results In FDA Trial Proving Safety And Efficacy 10/11/2005
More...
|
Miravant's (MRVT) Confirmatory Phase III Clinical Trial Of PHOTREX(TM) In Patients With Age-Related Macular Degeneration Is Underway 10/10/2005
More...
|
Pfizer Inc. (PFE) Release: Recent Analyses Suggest That Treatment With Macugen(R) (Pegaptanib Sodium Injection) May Provide Better Results For Patients With Early Stage Neovascular Age-Related Macular Degeneration (AMD) 10/5/2005
More...
|
Acuity Medical Focuses On Treatment For Age-Related Macular Degeneration 10/3/2005
More...
|
QLT Inc. (QLTI) Announces 2 Year Results Of Visudyne(R) In Occult (VIO) Trial; Primary End Point Not Achieved 9/21/2005
More...
|
Pfizer Inc. (PFE) Release: Macugen Receives Positive Opinion From Europe's CHMP For Treatment Of Wet Age-Related Macular Degeneration 9/16/2005
More...
|
Cigarettes Linked To Late-Life Blindness 9/8/2005
More...
|
FDA Denies Genentech, Inc. (DNA) Request To Fast-Track Lucentis; Company Plans Application In December 9/7/2005
More...
|
Gene Linked To Age-Related Blindness 8/23/2005
More...
|
Immusol, Inc. Announces License Agreement For Wet AMD Target With The University of Kentucky 8/16/2005
More...
|
TargeGen, Inc. Selects Lead Drug For Clinical Development As A Topical Treatment For Wet Macular Degeneration And Other Eye Diseases 7/29/2005
More...
|
Genentech, Inc. (DNA) Release: Phase III Study Shows Lucentis(TM) Improved Vision In Patients With Wet Age-Related Macular Degeneration 7/18/2005
More...
|
OccuLogix Inc. (RHEO): Positive PERC Data Presented At ASRS 2005 Annual Meeting 7/18/2005
More...
|
Genaera Corporation (GENR) Presents Clinical Results For EVIZON(TM) For Treatment Of Age-Related Macular Degeneration At The Annual Meeting Of The American Society Of Retina Specialists Meeting 7/18/2005
More...
|
Genentech, Inc. (DNA) Release: Preliminary Phase I/II Study Showed Lucentis(TM) Improved Vision In Patients With Wet Age-Related Macular Degeneration When Used In Combination With Visudyne(R) 7/18/2005
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) And Pfizer Inc. (PFE) Comment On Data Presented At Meeting Of Retinal Specialists 7/18/2005
More...
|
Pharmacopeia, Inc. (PCOP) Announces Agreement With Allergan Inc. (AGN) To Further Research Compounds For Age-Related Macular Degeneration (AMD) 7/12/2005
More...
|
Genentech, Inc. (DNA) Announces July 18 Webcast Discussion Of Data Presented At ASRS 7/6/2005
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Initiates VEGF Trap Intravitreal Clinical Development Program As Potental Treatment For Eye Diseases 7/5/2005
More...
|
Genaera Corporation (GENR) Initiates Phase III Macular Degeneration Clinical Trial For EVIZON(TM) 6/30/2005
More...
|
Genaera Corporation (GENR) Completes Special Protocol Assessment With FDA For EVIZON(TM) In Age-Related Macular Degeneration 6/27/2005
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Raises Full-Year Sales Forecast For Macugen(R) (Pegaptanib Sodium Injection); Stocks Up 6/22/2005
More...
|
Genaera Corporation (GENR) Reaches Target Enrollment In EVIZON(TM) Phase II Trial (MSI-1256F-209) In Age-Related Macular Degeneration 6/8/2005
More...
|
Sirna Therapeutics, Inc. (RNAI) To Present Interim Phase 1 Clinical Trial Data At American Society of Gene Therapy 6/2/2005
More...
|
Genentech, Inc. (DNA) Release: Preliminary Phase I And II Data Show Lucentis(TM) In Combination With Visudyne(R) Maintained Or Improved Vision In Approximately 90 Percent Of Patients With Wet Age-Related Macular Degeneration 5/31/2005
More...
|
Alcon Laboratories, Inc. (ACL) Receives Approvable Letter From FDA For RETAANE Suspension 5/25/2005
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Announces Conference Call To Reiterate Confidence In Macugen(R) (Pegaptanib Sodium Injection) 5/25/2005
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Announces Approval Of Macugen(R) In Canada For The Treatment Of Neovascular (Wet) Age Related Macular Degeneration 5/6/2005
More...
|
Oxford BioMedica PLC (OXB.L) Present Encouraging Preclinical Data 5/6/2005
More...
|
HF1 Gene Implicated In Age-related Macular Degeneration 5/6/2005
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Release: Macugen(R) Studied In Treatment Of Diabetic Macular Edema (DME) And Other Diabetic Retinopathy Lesions 5/5/2005
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) Release: Clinical And Pre-Clinical Studies Of The VEGF Trap Show Potential For The Treatment Of Neovascular Eye Diseases 5/4/2005
More...
|
Sirna Therapeutics (RNAI) Announces Results From Interim Analysis Of Phase 1 Single Dose Trial With Sirna-027 In Patients With Age-Related Macular Degeneration 5/4/2005
More...
|
Genaera Corporation (GENR) Announces Positive Interim EVIZON(TM) Phase II (MSI-1256F-208) AMD Data At Annual Association for Research in Vision & Ophthalmology Meeting 5/3/2005
More...
|
Eyetech Pharmaceuticals, Inc. (EYET) Release: Safety Profile Of Macugen(R) (pegaptanib sodium injection) In The Treatment Of Neovascular Age-Related Macular Degeneration (AMD) Maintained For Two Years 5/3/2005
More...
|
IRIDEX (IRIX) Announces Confirmation Of Favorable Age-Related Macular Degeneration (AMD) Results In TTT4CNV Clinical Trial Sub-Group 5/3/2005
More...
|
Novadaq Technologies, Inc. Appoints Dr. Devenyi Chief Opthamalogical Advisor 5/2/2005
More...
|
Genaera Corporation (GENR) To Present EVIZON(TM) Phase II AMD Data At The Association For Research In Vision And Ophthalmology Annual Meeting 4/21/2005
More...
|
Bionic Eye Will Let The Blind See 4/5/2005
More...
|
ParAllele Bioscience, Inc. And University of Iowa Collaborate To Discover Genes Responsible For Macular Degeneration 3/29/2005
More...
|
Allergan Inc. (AGN) And Sanwa Kagaku Kenkyusho Sign Exclusive Licensing Agreement To Develop And Market POSURDEX(R) In Japan 3/28/2005
More...
|
Light Sciences Release: Litx(TM) To Be Highlighted At First Drug And Device Summit 3/23/2005
More...
|
UT Southwestern Medical Center: 3 Studies Link Variant Gene To Risk of Severe Vision Loss 3/11/2005
More...
|
Rockefeller University: Researchers Identify Gene That Plays Major Role In Age-Related Blindness Disease 3/11/2005
More...
|
Researchers Discover Gene Believed Responsible for Age-Related Macular Degeneration 3/11/2005
More...
|
Miravant (MRVT) To Initiate PHOTREX Confirmatory Phase III Clinical Trial In Europe; Global CRO Kendle Selected To Provide Clinical Development And Trial Management Services 3/10/2005
More...
|
Quark Biotech, Inc. Discovers Role Of RTP801 In The Development Of Age-related Macular Degeneration 3/10/2005
More...
|
Complement Factor Polymorphism Linked To Age-related Macular Degeneration 3/10/2005
More...
|
Genaera Corporation (GENR) Announces 2004 Financial Results 3/3/2005
More...
|
Novadaq Technologies, Inc. Reports Encouraging Results In Wet AMD Study 3/1/2005
More...
|
OccuLogix Inc. (RHEO) Receives FDA Clearance To Initiate MIRA-1 Crossover Studies 2/28/2005
More...
|
Genaera Corporation (GENR) Announces Positive Preliminary Data For EVIZON(TM) In Treating Age-Related Macular Degeneration At The Macula Society Meeting 2/25/2005
More...
|
Alnylam Pharmaceuticals (ALNY) Data Presented On RNAi Therapeutics For Age-Related Macular Degeneration; Preclinical Data Reported At The Macula Society Meeting 2/25/2005
More...
|
OXiGENE (OXGN) Reports Fourth-Quarter And Year-End 2004 Financial Results 2/25/2005
More...
|
IRIDEX (IRIX) Announces Favorable TTT4CNV Clinical Trial Sub-Group Results 2/24/2005
More...
|
GenVec Inc. (GNVC) Expands Clinical Testing Of AdPEDF For Macular Degeneration 2/22/2005
More...
|
Sirna Therapeutics (RNAI) Reports 2004 Fourth Quarter And Full Year Financial Results 2/18/2005
More...
|
Alimera Sciences And Control Delivery Systems Announce Collaboration Agreement On A New Pharmacologic Treatment For Diabetic Macular Edema 2/16/2005
More...
|
Genaera Corporation (GENR) Reaches Target Enrollment In Two Phase II Studies For Squalamine In Age-Related Macular Degeneration 2/15/2005
More...
|